• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Shp2在Ras/丝裂原活化蛋白激酶(ERK1/2)信号通路中的分子功能。

The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.

作者信息

Dance Marie, Montagner Alexandra, Salles Jean-Pierre, Yart Armelle, Raynal Patrick

机构信息

INSERM U563, Département Lipoprotéines et Médiateurs Lipidiques, Site Purpan, Toulouse, France.

出版信息

Cell Signal. 2008 Mar;20(3):453-9. doi: 10.1016/j.cellsig.2007.10.002. Epub 2007 Oct 11.

DOI:10.1016/j.cellsig.2007.10.002
PMID:17993263
Abstract

Shp2 is a ubiquitous tyrosine phosphatase containing Src Homology 2 domains which plays major biological functions in response to various growth factors, hormones or cytokines. This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway. Recent progresses have been made in the understanding of the molecular mechanisms involved in this regulation. We review here, and discuss the physiological relevance, of the following molecular functions of Shp2 that have been proposed to couple the phosphatase to Ras activation: promoter of Grb2/Sos recruitment through direct binding to Grb2, binding partner and regulator of SHPS-1, negative regulator of Sprouty, negative regulator of RasGAP recruitment, and activator of Src through dephosphorylation of Src-regulatory proteins.

摘要

Shp2是一种普遍存在的含Src同源2结构域的酪氨酸磷酸酶,在对各种生长因子、激素或细胞因子的应答中发挥主要生物学功能。这主要归因于其促进Ras/丝裂原活化蛋白激酶途径激活的特性。在理解参与这种调节的分子机制方面已取得了最新进展。在此,我们回顾并讨论已提出的Shp2的以下分子功能的生理相关性,这些功能将磷酸酶与Ras激活联系起来:通过直接结合Grb2促进Grb2/Sos募集、SHPS-1的结合伴侣和调节剂、Sprouty的负调节剂、RasGAP募集的负调节剂以及通过使Src调节蛋白去磷酸化来激活Src。

相似文献

1
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.Shp2在Ras/丝裂原活化蛋白激酶(ERK1/2)信号通路中的分子功能。
Cell Signal. 2008 Mar;20(3):453-9. doi: 10.1016/j.cellsig.2007.10.002. Epub 2007 Oct 11.
2
The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.蛋白酪氨酸磷酸酶Shp2是脑源性神经营养因子完全激活RAS/MAPK通路所必需的。
J Neurochem. 2006 May;97(3):834-45. doi: 10.1111/j.1471-4159.2006.03789.x. Epub 2006 Mar 29.
3
Hypophosphorylated TCR/CD3zeta signals through a Grb2-SOS1-Ras pathway in Lck knockdown cells.在Lck基因敲低的细胞中,低磷酸化的TCR/CD3ζ通过Grb2-SOS1-Ras信号通路进行信号传导。
Eur J Immunol. 2007 Sep;37(9):2539-48. doi: 10.1002/eji.200636973.
4
Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth.β4整合素激活一条Shp2-Src信号通路,该通路维持肝细胞生长因子诱导的不依赖贴壁的生长。
J Cell Biol. 2006 Dec 18;175(6):993-1003. doi: 10.1083/jcb.200605114. Epub 2006 Dec 11.
5
Three-dimensional matrix induces sustained activation of ERK1/2 via Src/Ras/Raf signaling pathway.三维基质通过Src/Ras/Raf信号通路诱导ERK1/2的持续激活。
Cell Biol Int. 2008 Feb;32(2):229-34. doi: 10.1016/j.cellbi.2007.08.029. Epub 2007 Sep 7.
6
Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.信号强度通过不同的Gab1/Shp2募集决定磷脂酰肌醇3激酶对Ras/细胞外信号调节激酶1和2激活的作用:对表皮生长因子受体抑制耐药性的影响。
Mol Cell Biol. 2008 Jan;28(2):587-600. doi: 10.1128/MCB.01318-07. Epub 2007 Nov 19.
7
Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation.前列腺素E1通过特异性干扰白细胞介素-6(IL-6)依赖的细胞外信号调节激酶1/2(ERK1/2),而非信号转导和转录激活因子3(STAT3)的激活,来抑制IL-6诱导的单核细胞趋化蛋白-1(MCP-1)表达。
Biochem J. 2008 May 15;412(1):65-72. doi: 10.1042/BJ20071572.
8
Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.G(i/o)的βγ亚基抑制表皮生长因子(EGF)诱导的细胞外信号调节激酶5(ERK5)磷酸化,而细胞外信号调节激酶1/2(ERK1/2)的磷酸化则增强。
Cell Signal. 2008 Jul;20(7):1275-83. doi: 10.1016/j.cellsig.2008.02.016. Epub 2008 Mar 4.
9
The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.多站点对接蛋白 Grb2 相关结合蛋白 1(Gab1)以 SHP2、Grb2 和时间依赖的方式增强白细胞介素 6 诱导的 MAPK 通路激活。
Cell Commun Signal. 2019 Oct 24;17(1):135. doi: 10.1186/s12964-019-0451-2.
10
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.SHP2对丝裂原活化蛋白激酶信号通路的调控
J Biol Chem. 2002 Mar 15;277(11):9498-504. doi: 10.1074/jbc.M110547200. Epub 2002 Jan 4.

引用本文的文献

1
Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients?KRAS 基因突变型胰腺癌的治疗:患者的新希望?
Cancers (Basel). 2025 Jul 24;17(15):2453. doi: 10.3390/cancers17152453.
2
Targeting SHP2 with Natural Products: Exploring Saponin-Based Allosteric Inhibitors and Their Therapeutic Potential.利用天然产物靶向SHP2:探索基于皂苷的变构抑制剂及其治疗潜力。
Curr Issues Mol Biol. 2025 Apr 27;47(5):309. doi: 10.3390/cimb47050309.
3
Proximity-labeling proteomics reveals remodeled interactomes and altered localization of pathogenic SHP2 variants.
邻近标记蛋白质组学揭示了致病性SHP2变体的重塑相互作用组和改变的定位。
bioRxiv. 2025 Mar 21:2025.02.26.640373. doi: 10.1101/2025.02.26.640373.
4
Multiplexed single-cell transcriptomics reveals diverse phenotypic outcomes for pathogenic SHP2 variants.多重单细胞转录组学揭示了致病性SHP2变体的多种表型结果。
bioRxiv. 2025 Jul 2:2025.06.30.662374. doi: 10.1101/2025.06.30.662374.
5
Drugging the 'undruggable' KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer.靶向“不可成药”的KRAS:胰腺癌治疗的突破、挑战与机遇
Cancer Biol Med. 2025 Jul 7. doi: 10.20892/j.issn.2095-3941.2025.0122.
6
Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer.肿瘤相关巨噬细胞衍生的外泌体环状PLK1促进非小细胞肺癌对表皮生长因子受体抑制剂奥希替尼的耐药性。
Discov Oncol. 2025 Jul 1;16(1):1196. doi: 10.1007/s12672-025-03025-w.
7
PTPN11 in cartilage development, adult homeostasis, and diseases.蛋白酪氨酸磷酸酶非受体型11在软骨发育、成人内稳态及疾病中的作用
Bone Res. 2025 May 16;13(1):53. doi: 10.1038/s41413-025-00425-0.
8
Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase.靶向SHP2磷酸酶C-SH2结构域的肽抑制剂的开发
Chembiochem. 2025 May 27;26(10):e202400938. doi: 10.1002/cbic.202400938. Epub 2025 May 16.
9
KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy.癌症中的KRAS突变:理解免疫调节的信号通路及免疫疗法的潜力
Cancers (Basel). 2025 Feb 25;17(5):785. doi: 10.3390/cancers17050785.
10
Recent advances in targeted degradation in the RAS pathway.RAS 信号通路中靶向降解的最新进展。
Future Med Chem. 2025 Mar;17(6):693-708. doi: 10.1080/17568919.2025.2476387. Epub 2025 Mar 10.